Column | Enterprise Risk Management

Assessing Risk in Healthcare Finance Calls for Stewardship

Column | Enterprise Risk Management

Assessing Risk in Healthcare Finance Calls for Stewardship

Amid the healthcare industry’s ongoing transformation, healthcare leaders are called upon to be stewards in guiding their organizations through change and managing financial and operational risk.

How much risk is too much? What’s not enough? These questions have been at the heart of many healthcare leader discussions over the past decade.

Our industry has pivoted in strategy to focus on value-based care and population health management, prompting vast investments in infrastructure, talent, scale, and innovation to create a new financial and operational risk profile for healthcare organizations. Meanwhile, the regulatory environment ebbs and flows with changes in leadership and policy at the federal and state levels, with different cadences and twists according to each market’s unique characteristics.

At the root of this transformation, healthcare leaders, board members, and physicians are called to be stewards. They must consider what’s been entrusted to them while gauging the risks and benefits of action or inaction in the context of their local communities and organizational strategy. Many have embraced the perspective expressed by Mark Zuckerberg: “In a world that’s changing really quickly, the only strategy that is guaranteed to fail is not taking risks.”

Against this backdrop, finance professionals are at the center of teams “leading the change,” developing complex risk-mitigation tactics to anticipate possible trends, outcomes, and implications for significant risks to their organizations. As they rigorously execute strategy, they weave in these tactics to create an integrated enterprise risk framework aligned with the organization’s overall strategy and direction.

Among the most common mitigation tactics are cadence, resource allocation, and collaboration. Staged deployment of strategy, or the cadence of change, aligns the pace of internal change and resource consumption with demand and acceptance from the external environment. For example, if we create a solution that payers are unwilling to pay for or consumers are unwilling to adopt, we take on significant risk. A staged deployment, however, creates decision points along the change curve to ensure the appropriate amount of risk supports the time interval.

Another tactic is allocating a specific amount of energy, time, and resources to invest in innovation outside of core service lines. The result is a shared, clearly delineated understanding of what and how much risk the organization can take, for how long, and to what degree, thereby enabling the organization to have a higher risk tolerance within a well-defined, narrow scope and strategy.

The third tactic is collaboration versus creation. Partnerships, acquisitions, and collaboration create value by flexibly and speedily providing access to the expertise, risk-bearing capabilities, scale, and influence needed for success. The delay to market, external competitors, and overall scarcity of resources have lowered past hurdles between organizations related to a need for exclusive control and autonomy.

There’s no one magic answer to the risk question. Instead, it’s a matter of stewardship—and diligently defining it, one organization at a time.

About the Author

Carol A. Friesen, FHFMA, MPH,

is HFMA's 2017-18 National Chair. 

Advertisements

Related Articles | Enterprise Risk Management

News | Coronavirus

Healthcare News of Note: Federal bailout money helped some of the nation’s wealthier hospitals prosper despite COVID-19

Healthcare News of Note for healthcare finance professionals is a roundup of recent news articles, including wealthier hospitals prospering despite COVID-19, oncologists seeing more new advanced-stage cancer patients and the burden of prior authorizations during COVID.

Sponsored Content | Value-Based Payment

Implications of the HFMA-GHX study of risk-based contracting

In this article discussing implications of the findings of a December 2020 HFMA study, sponsored by GHX, healthcare leaders share their perspectives on key factors contributing to their organizations' success under value-based contracts.

Trend | Strategic Partnerships Mergers and Acquisitions

Healthcare M&A: Are you prepared for the pitfalls?

Leaders of hospitals and health systems whose organizations are embarking on a merger or acquisition should be prepared to avoid the many potential pitfalls associated with such an strategic venture.

News | Coronavirus

Healthcare News of Note: Hospitals await disbursement of remaining COVID-19 relief funds

Healthcare News of Note for healthcare finance professionals is a roundup of recent news articles, including hospitals waiting on COVID-19 relief funds, HHS postponing implementation of the SUNSET rule and confirmation of a new HHS assistant secretary for health who is the first openly transgender person to be confirmed for a position by the Senate.